{"date":"2025-06-03","count":37,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6949-2025-06-03-1939-xwssao","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-06-03","time":"19:39:36","subject":"公告本公司取得會計師113年內部控制專案審查報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-06-03 19:39，「公告本公司取得會計師113年內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-06-03-1847-1n3kr2b","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"18:47:02","subject":"公告本公司董事長訂定除息基準日及發放日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-06-03 18:47，「公告本公司董事長訂定除息基準日及發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-06-03-1818-11al93r","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"18:18:26","subject":"本公司「人類臍帶間質幹細胞外泌體 (Human UmbilicalMesenchymal Stem Cell Exosomes)」經美國個人護理產品協會(PCPC)審查通過，獲國際INCI新原料認證(INCI name)","clause":"第44款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-06-03 18:18，「本公司「人類臍帶間質幹細胞外泌體 (Human UmbilicalMesenchymal Stem Cell Exoso」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-06-03-1756-1vzefk3","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-06-03","time":"17:56:27","subject":"公告本公司受邀參加宏遠證券舉辦之線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-06-03 17:56，「公告本公司受邀參加宏遠證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-06-03-1714-nm2vob","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"17:14:21","subject":"公告本公司股東會決議解除董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-06-03 17:14，「公告本公司股東會決議解除董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-06-03-1713-t6rqxo","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"17:13:26","subject":"公告本公司114年股東常會重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-06-03 17:13，「公告本公司114年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2025-06-03-1710-rn8mu6","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2025-06-03","time":"17:10:31","subject":"本公司受邀參加第一金證券舉辦之投資論壇","clause":"第12款","fact_date":"2025-06-12","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2025-06-03 17:10，「本公司受邀參加第一金證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-06-03-1704-1xn1zfa","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"17:04:34","subject":"公告本公司董事長訂定除息除權基準日","clause":"第14款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-06-03 17:04，「公告本公司董事長訂定除息除權基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-06-03-1635-16h9ko2","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"16:35:13","subject":"公告本公司董事會決議召開114年第二次股東臨時會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-06-03 16:35，「公告本公司董事會決議召開114年第二次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-06-03-1632-1cugv11","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"16:32:19","subject":"公告本公司114年股東常會通過解除本公司董事及其代表人競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-06-03 16:32，「公告本公司114年股東常會通過解除本公司董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-06-03-1630-ds864w","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"16:30:56","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-06-03 16:30，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-06-03-1630-1s9s8up","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:30:00","subject":"公告本公司法人董事代表人解任","clause":"第6款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-06-03 16:30，「公告本公司法人董事代表人解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-06-03-1618-hiebb2","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"16:18:32","subject":"公告本公司114年股東會重要決議事項","clause":"第15款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-06-03 16:18，「公告本公司114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-06-03-1618-lfcj7","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:18:00","subject":"公告本公司第二屆薪酬委員會成員任期屆滿","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-06-03 16:18，「公告本公司第二屆薪酬委員會成員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-06-03-1617-1cd4aao","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:17:47","subject":"公告本公司第三屆審計委員會委員及推舉審計委員會召集人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-06-03 16:17，「公告本公司第三屆審計委員會委員及推舉審計委員會召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-06-03-1617-1o57grg","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:17:31","subject":"公告本公司114年度股東常會決議解除新任董事及獨立董事之競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-06-03 16:17，「公告本公司114年度股東常會決議解除新任董事及獨立董事之競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-06-03-1617-9769qc","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:17:11","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-06-03 16:17，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-06-03-1616-bww4av","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:16:44","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-06-03 16:16，「公告本公司114年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-06-03-1615-d9bwy4","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:15:37","subject":"公告本公司114年度股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-06-03 16:15，「公告本公司114年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-06-03-1605-187gtq6","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:05:29","subject":"公告本公司審計委員會委員任期屆滿及新任名單","clause":"第6款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-06-03 16:05，「公告本公司審計委員會委員任期屆滿及新任名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-06-03-1605-sqgrt0","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"16:05:09","subject":"公告本公司法人董事代表人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-06-03 16:05，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-06-03-1604-rw071h","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:04:28","subject":"公告本公司薪資報酬委員會委員任期屆滿及新任名單","clause":"第6款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-06-03 16:04，「公告本公司薪資報酬委員會委員任期屆滿及新任名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-06-03-1604-e280bm","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:04:01","subject":"公告本公司114年股東常會全面改選董事暨三分之一以上董事發生變動","clause":"第6款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-06-03 16:04，「公告本公司114年股東常會全面改選董事暨三分之一以上董事發生變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-06-03-1603-1v8yxnu","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:03:30","subject":"公告本公司114年股東常會通過解除本公司新任董事競業禁止限制","clause":"第22款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-06-03 16:03，「公告本公司114年股東常會通過解除本公司新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-06-03-1602-12bp3uu","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:02:55","subject":"公告本公司新選任法人董事指派之代表人","clause":"第6款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-06-03 16:02，「公告本公司新選任法人董事指派之代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-06-03-1602-9769qc","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:02:23","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-06-03 16:02，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-06-03-1601-ds864w","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"16:01:54","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-06-03 16:01，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-06-03-1551-54an5","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"15:51:48","subject":"本公司三特異性抗體抗癌新藥SOA101獲台灣衛生福利部食品藥物管理署(TFDA)准予治療實體腫瘤(Solid Tumors)Phase I/IIa 人體臨床試驗執行","clause":"第8款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-06-03 15:51，「本公司三特異性抗體抗癌新藥SOA101獲台灣衛生福利部食品藥物管理署(TFDA)准予治療實體腫瘤(Solid Tumor」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2025-06-03-1517-14lrh54","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2025-06-03","time":"15:17:25","subject":"本公司受邀參加兆豐證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2025-06-03 15:17，「本公司受邀參加兆豐證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-06-03-1510-1vhu1xi","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"15:10:16","subject":"公告本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-06-03 15:10，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-06-03-1509-1jaof8b","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"15:09:32","subject":"公告本公司113年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-06-03 15:09，「公告本公司113年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-06-03-1450-m2f20h","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"14:50:14","subject":"公告本公司一一四年股東常會通過解除董事競業禁止之限制","clause":"第22款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-06-03 14:50，「公告本公司一一四年股東常會通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-06-03-1448-n6wuuk","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"14:48:06","subject":"公告本公司第一屆審計委員會委員名單","clause":"第6款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-06-03 14:48，「公告本公司第一屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-06-03-1436-4anrsd","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"14:36:01","subject":"公告本公司一一四年股東常會選舉第三屆董事(含獨立董事四席)當選名單","clause":"第6款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-06-03 14:36，「公告本公司一一四年股東常會選舉第三屆董事(含獨立董事四席)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-06-03-1431-ds864w","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"14:31:06","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-06-03 14:31，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-06-03-1128-ds864w","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-06-03","time":"11:28:12","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-03","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-06-03 11:28，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-06-03-0944-1aq7iqo","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-03","time":"09:44:10","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"第30款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-06-03 09:44，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}